Results of the Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc®-L Total Disc Replacement Versus Circumferential Fusion for the Treatment of 1-Level Degenerative Disc Disease : Spine

Secondary Logo

Journal Logo

Randomized Trial

Results of the Prospective, Randomized, Multicenter Food and Drug Administration Investigational Device Exemption Study of the ProDisc®-L Total Disc Replacement Versus Circumferential Fusion for the Treatment of 1-Level Degenerative Disc Disease

Zigler, Jack MD*; Delamarter, Rick MD; Spivak, Jeffrey M. MD§§§; Linovitz, Raymond J. MD, FACS§; Danielson, Guy O. III MD; Haider, Thomas T. MD; Cammisa, Frank MD#; Zuchermann, Jim MD**; Balderston, Richard MD††; Kitchel, Scott MD‡‡; Foley, Kevin MD§§; Watkins, Robert MD∥∥; Bradford, David MD¶¶; Yue, James MD##; Yuan, Hansen MD***; Herkowitz, Harry MD†††; Geiger, Doug MD‡‡‡; Bendo, John MD§§§; Peppers, Timothy MD§; Sachs, Barton MD*; Girardi, Federico MD#; Kropf, Michael MD; Goldstein, Jeff MD§§§

Author Information
Spine 32(11):p 1155-1162, May 15, 2007. | DOI: 10.1097/BRS.0b013e318054e377

© 2007 Lippincott Williams & Wilkins, Inc.

You can read the full text of this article if you:

Access through Ovid